Surgical Innovations Group PLC (SUN)

Industry Medical Devices


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

0.40p

Buy

0.50p

arrow-up0.00p (+0.00%)

Prices updated at 19 Dec 2025, 12:02 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Surgical Innovations Group PLC is principally involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery (SI) and precision engineering markets (PE).

Income statement

20232024
12m12m
3m3m
-588,000-638,000
-4.89-5.34
-509,000-2m
161,000-99,000
Sales, General and administrative3m3m
Interest expenses132,00099,000
Provision for income taxes-219,000-107,000
Operating expenses4m4m
Income before taxes-728,000-2m
Net income available to common shareholders-509,000-2m
-0.0006-0.0021
Net interest income-132,000-99,000
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-0.0006-0.0021
Free cash flow per share-0.001-0.0006
Book value/share0.01140.0107
Debt equity ratio0.1002480.081606

Balance sheet

20232024
Current assets6m5m
Current liabilities3m3m
Total capital11m9m
Total debt2m1m
Total equity10m9m
Total non current liabilities--
Loans502,000150,000
Total assets14m12m
Total liabilities--
Cash and cash equivalents1m195,000
Common stock933m933m

Cash flow

20232024
Cash at beginning of period2m1m
Cash dividends paid--
-288,000-409,000
Investments (gains) losses-688,000-335,000
1m195,000
Net income--
400,000-74,000
-688,000-335,000
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.